A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension

NCT00051194 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-angle
Ocular Hypertension

Interventions

DRUG: Combination IOP Lowering Therapy

Sponsor

Alcon Research